Pharmaceutical Commerce - May/June 2015

While the pharma industry is growing more dependent on companion diagnostics, test developers face an uncertain business model

Logistics managers in life sciences and personal care focus on transportation capacity

Combining high-quality patient-support services with comprehensive and continually updated analytics results in better outcomes

The growing number of certifications has become a competitive issue for SPPs bidding for Pharma's business

Meeting the compliance deadlines of the Drug Supply Chain Security Act has the attention of many in biopharma product and brand security

As new cancer drugs with promising efficacy but brutal costs enter the market, providers, payers and manufacturers are strategizing new payment approaches

Heightened concern over adherence and product stability may win over more pharma clients

Effect of the first full year of Obamacare was muted, although a record number of prescriptions were written

Company targets evolving regenerative medicine market

$4.8-billion deal follows UPS' failed effort in 2013

Leading copay-coupon provider expands its patient services with private equity help

Do you know your J codes?

Creation of a holding company streamlines future acquisitions; focus is on specialty drug services

Company wins $10 million in venture capital as it lines up key life sciences service providers